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INTRODUCTION
Exophthalmos (also called exophthalmia or proptosis) 
is a bulging of the eye anteriorly out of the orbit. Ex-
ophthalmos can be bilateral as is often seen in Grave’s 
disease. In the case of Grave’s Disease, the displace-
ment of the eye is due to abnormal connective tissue 
deposition in the orbit and extra ocular muscles which 
can be visualized by Computed tomography (CT) or 
Magnetic resonance imaging (MRI). If left untreated, 
exophthalmos can cause the eyelids to fail to close 
during sleep leading to corneal dryness and damage. 
Another possible complication would be a form of 
redness or irritation, called ‟superior limbic kerato-
conjunctivitis’’, where the area above the cornea be-
comes inflamed as a result of increased friction when 
blinking. The process that is causing the displacement 
of the eye may also compress the optic nerve or oph-
thalmic artery, leading to blindness.
CASE REPORT
A 61- year-old man with significant bilateral exoph-
thalmos (of the right eye was more well-defined) was 
presented to our department. The patient had oph-
thalmic symptoms involving periorbital soft tissues, 
eyelids, oculomotor muscles and even optic nerves . 
He was with decreased movement range of eyeballs, 
(±) in creased exophthalmos,diplopia and lacrima-
tion(+), (±) eyeball pain. He was treated for 45 days 
after diagnosis (December 2007) with corticosteroid 
per os (medrol 24 mg/day) from endocrinologist. As 
there was no big improvement of the symptoms, he 
came to our Radiotherapy department for irradiation. 
Diagnosis of ophthalmopathy is mainly based on clin-
ical data. The aim of ophthalmological examination 
is to assess the state of eyelids, conjunctivas, exoph-
thalmos, oculo-motor muscle disfunction, cornea and 
visual acuity. Ambulatory irradiation of retro bulbar 
areas was performed in the Radiotherapy Department 
in University Hospital AHEPA. Before the treatment 
initiation, an individual plexiglass mask was created 
for the patient which allowed the limits of irradiation 
fields to be reconstructed. CT simulation-examination 
was performed for therapy planning purposes. Irradia-
tion technique was based on exposing the retrobulbar 
area to the effect of two opposite, isocentric beams 
which would create one, common (flat) line from the 
lens direction. Dimensions of the irradiation field 
were within the limits of 4 cm x 5 cm6,8 (Figure 1, 2). 
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Figure 1.
Figure 2.
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Planned dosage of radiation was 20Gy applied in 12Fr. 
The 1st dose fraction was 1 Gy and 1,73Gy/Fr during 
the following 11 days (5 days a week)6. Control of 
treatment quality was performed by comparing portal 
images(created on the day the irradiation started )to 
Images from the treatment planning system5,6. At the 
end of the irradiation treatment, the therapy was con-
sidered to be successful result: increased movement 
range of eyeballs,decreased exophthalmos, decrease 
of diplopia and lacrimation, reduction of eyeball pain. 
The MRI in the orbit after three months of irradiation 
showed decrease thickening of straight muscles.
DISCUSSION
Radiotherapy has been for many years one of the 
methods used in treatment of ophthalmopathy occur-
ring in the course of Graves-Basedow disease12,13. It is 
significant that ophthalmopathy irradiation is accom-
panied by few side effects1,2. The disease is a result of 
an autoimmunological process3,10. Activated suppres-
sor T- lymphocytes infiltrate the muscles moving the 
eyeball which leads to their thickening. Patients with 
infiltrative ophthalmopathy in the course of Graves-
Basedow disease are qualified in our centre for irra-
diation treatment according to the following criteria: 
1) euthyreosis assessed on the basis of TSH, T3, T4, 
FT4 levels. 2) qualification for therapy by a consulting 
ophthalmologist. 3) Thinckening of straight muscles 
in both orbits, damaged optic nerve and enlargement 
of the lacrimal gland as showed by CT (computed 
tomography) or MRI (magnetic resonance) of or-
bital regions, is performed to find the cause of oph-
thalmic symptoms4. 4) Patient’s consent to proposed 
treatment. The aim of radiotherapy in the course of 
Graves Basedow disease is to eliminate radiosensi-
tive lymphocytic infiltrations of eyeball muscles and 
fibroblasts while preserving normal functions and 
anatomical structures localized inside the orbital cav-
ity. Planned dosage of radiation was 20Gy applied in 
12Fr. So the 1st fraction dose was 1 Gy and 1,73Gy/
Fr during the following 11 days (5 days a week)6. 
Corticosteroids and irradiation of retrobulbar areas 
are still important elements of treatment blocking lo-
cal inflammatory reaction and stabilizing the disease 
process. These methods lead to a reduction of exist-
ing symptoms in only 40%-70%5,11. In our case, there 
was not side effects after radiation therapy (lacrima-
tion and swelling of the eyelids, slight skin erythema), 
while the patient presented regression of the diplopia 
and improved visual activity.
CONCLUSIONS
In conclusion, the value of radiation therapy was in-
vestigated in this patient with Graves ‘ophthalmopa-
thy treated with orbital irradiation at the Radiotherapy 
Department of AHEPA University Hospital, Aristotle 
University of Thessaloniki. Irradiation was adminis-
tered with two opposed convergent beams tilted pos-
teriorlys 5-10 degrees with 20Gy/12Fr/2 weeks. The 
follow up consisted of endocrinologist and ophthal-
mologic tests and of post irradiation orbital MRI7,9. 
We point out that a combination of glucocorticoste-
roids with concurrent irradiation is the best form of 
ophthalmopathy treatment, in bilateral exophthalmos, 
in the course of Graves-Basedow disease.
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ΠΕΡΙΛΗΨΗ: Ο αμφοτερόπλευρος εξώφθαλμος στη νόσο του Grave’s εμφανίζεται σπάνια. Είναι συχνότερος σε ασθε-
νείς με θυρεοειδική οφθαλμοπάθεια. Aναφέρουμε μια περίπτωση αμφοτερόπλευρου κακοήθη εξώφθαλμο οφειλόμενη στη 
νόσο Grave’s Basedow, που έχει ακτινοβοληθεί στο τμήμα Ακτινοθεραπευτικής Ογκολογίας στο Πανεπιστημιακό Γενικό 
Νοσοκομείο ΑΧΕΠΑ του Αριστοτελείου Πανεπιστήμιου της Θεσσαλονίκης.
Λέξεις Κλειδιά: Εξώφθαλμος, Νόσος του Grave’s-Basedow, Ακτινοθεραπεία.
Ο θεραπευτικός ρόλος της ακτινοθεραπείας  
στον «αμφοτερόπλευρο εξώφθαλμο στη νόσο του Grave’s’».
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